Free Trial

PetVivo (PETV) Competitors

PetVivo logo
$0.78 0.00 (0.00%)
As of 09:46 AM Eastern

PETV vs. NNOX, SKIN, GUTS, LAKE, and NRXS

Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Nano-X Imaging (NNOX), Beauty Health (SKIN), Fractyl Health (GUTS), Lakeland Industries (LAKE), and NeurAxis (NRXS). These companies are all part of the "medical equipment" industry.

How does PetVivo compare to Nano-X Imaging?

Nano-X Imaging (NASDAQ:NNOX) and PetVivo (NASDAQ:PETV) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Nano-X Imaging has a net margin of -790.87% compared to PetVivo's net margin of -902.82%. Nano-X Imaging's return on equity of -64.65% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-790.87% -64.65% -57.27%
PetVivo -902.82%-4,813.07%-281.78%

PetVivo has lower revenue, but higher earnings than Nano-X Imaging. PetVivo is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$13.02M9.01-$75.02M-$1.59N/A
PetVivo$1.05M26.73-$10.95M-$0.38N/A

In the previous week, Nano-X Imaging had 5 more articles in the media than PetVivo. MarketBeat recorded 7 mentions for Nano-X Imaging and 2 mentions for PetVivo. Nano-X Imaging's average media sentiment score of 0.23 beat PetVivo's score of 0.00 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nano-X Imaging
0 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Nano-X Imaging currently has a consensus price target of $5.00, suggesting a potential upside of 178.55%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, research analysts plainly believe Nano-X Imaging is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
2 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
3 Strong Buy rating(s)
2.83
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Nano-X Imaging has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

Summary

Nano-X Imaging beats PetVivo on 11 of the 17 factors compared between the two stocks.

How does PetVivo compare to Beauty Health?

PetVivo (NASDAQ:PETV) and Beauty Health (NASDAQ:SKIN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Beauty Health has a net margin of -3.16% compared to PetVivo's net margin of -902.82%. Beauty Health's return on equity of -15.40% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
Beauty Health -3.16%-15.40%-1.74%

24.5% of PetVivo shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 40.3% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Beauty Health has higher revenue and earnings than PetVivo. Beauty Health is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M26.73-$10.95M-$0.38N/A
Beauty Health$300.80M0.38-$9.52M-$0.20N/A

In the previous week, Beauty Health had 9 more articles in the media than PetVivo. MarketBeat recorded 11 mentions for Beauty Health and 2 mentions for PetVivo. Beauty Health's average media sentiment score of 1.06 beat PetVivo's score of 0.00 indicating that Beauty Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Beauty Health
8 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Beauty Health has a consensus price target of $2.32, suggesting a potential upside of 157.78%. Given Beauty Health's stronger consensus rating and higher possible upside, analysts plainly believe Beauty Health is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Beauty Health
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

PetVivo has a beta of 1.27, indicating that its stock price is 27% more volatile than the S&P 500. Comparatively, Beauty Health has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500.

Summary

Beauty Health beats PetVivo on 13 of the 16 factors compared between the two stocks.

How does PetVivo compare to Fractyl Health?

PetVivo (NASDAQ:PETV) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

Fractyl Health has a consensus price target of $5.40, suggesting a potential upside of 686.03%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts clearly believe Fractyl Health is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Fractyl Health
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Fractyl Health has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. Fractyl Health's return on equity of -2,896.77% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-902.82% -4,813.07% -281.78%
Fractyl Health N/A -2,896.77%-104.24%

In the previous week, Fractyl Health had 1 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for Fractyl Health and 2 mentions for PetVivo. Fractyl Health's average media sentiment score of 1.90 beat PetVivo's score of 0.00 indicating that Fractyl Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Fractyl Health
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

PetVivo has higher revenue and earnings than Fractyl Health. PetVivo is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$1.05M26.73-$10.95M-$0.38N/A
Fractyl HealthN/AN/A-$140.95M-$1.84N/A

24.5% of PetVivo shares are held by institutional investors. 10.8% of PetVivo shares are held by insiders. Comparatively, 26.1% of Fractyl Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

PetVivo has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Fractyl Health has a beta of 2.11, indicating that its share price is 111% more volatile than the S&P 500.

Summary

Fractyl Health beats PetVivo on 11 of the 15 factors compared between the two stocks.

How does PetVivo compare to Lakeland Industries?

Lakeland Industries (NASDAQ:LAKE) and PetVivo (NASDAQ:PETV) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends, media sentiment and analyst recommendations.

Lakeland Industries presently has a consensus price target of $15.20, suggesting a potential upside of 62.79%. Given Lakeland Industries' stronger consensus rating and higher possible upside, analysts clearly believe Lakeland Industries is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lakeland Industries
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Lakeland Industries has a net margin of -13.14% compared to PetVivo's net margin of -902.82%. Lakeland Industries' return on equity of -9.57% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
Lakeland Industries-13.14% -9.57% -6.06%
PetVivo -902.82%-4,813.07%-281.78%

In the previous week, PetVivo had 1 more articles in the media than Lakeland Industries. MarketBeat recorded 2 mentions for PetVivo and 1 mentions for Lakeland Industries. Lakeland Industries' average media sentiment score of 0.00 equaled PetVivo'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Lakeland Industries
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PetVivo has lower revenue, but higher earnings than Lakeland Industries. Lakeland Industries is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lakeland Industries$192.65M0.48-$25.31M-$2.58N/A
PetVivo$1.05M26.73-$10.95M-$0.38N/A

71.7% of Lakeland Industries shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 1.9% of Lakeland Industries shares are held by insiders. Comparatively, 10.8% of PetVivo shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Lakeland Industries has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500.

Summary

Lakeland Industries beats PetVivo on 9 of the 15 factors compared between the two stocks.

How does PetVivo compare to NeurAxis?

NeurAxis (NASDAQ:NRXS) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 15.2% of NeurAxis shares are held by company insiders. Comparatively, 10.8% of PetVivo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

NeurAxis presently has a consensus price target of $13.00, suggesting a potential upside of 49.72%. Given NeurAxis' stronger consensus rating and higher probable upside, equities research analysts clearly believe NeurAxis is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeurAxis
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

NeurAxis has a net margin of -492.76% compared to PetVivo's net margin of -902.82%. NeurAxis' return on equity of 0.00% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
NeurAxis-492.76% N/A -641.25%
PetVivo -902.82%-4,813.07%-281.78%

NeurAxis has a beta of 1.5, suggesting that its share price is 50% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500.

In the previous week, NeurAxis and NeurAxis both had 2 articles in the media. NeurAxis' average media sentiment score of 0.55 beat PetVivo's score of 0.00 indicating that NeurAxis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeurAxis
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

PetVivo has lower revenue, but higher earnings than NeurAxis. NeurAxis is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeurAxis$3.57M27.99-$14.63M-$0.94N/A
PetVivo$1.05M26.73-$10.95M-$0.38N/A

Summary

NeurAxis beats PetVivo on 10 of the 15 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$27.96M$45.93M$6.25B$11.87B
Dividend YieldN/A1.08%2.73%5.21%
P/E Ratio-1.7318.5429.0328.47
Price / Sales26.7330.61476.1060.92
Price / CashN/A18.8827.6236.52
Price / Book-26.0014.279.676.67
Net Income-$10.95M-$20.10M$3.55B$332.53M
7 Day Performance-2.37%-1.31%1.75%2.03%
1 Month Performance5.05%-1.55%5.66%9.23%
1 Year Performance23.61%10.87%34.42%39.62%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.78
flat
N/AN/A$27.96M$1.05MN/A20
NNOX
Nano-X Imaging
2.6948 of 5 stars
$1.73
+1.2%
$5.00
+189.0%
N/A$111.81M$13.02MN/A190
SKIN
Beauty Health
3.2383 of 5 stars
$0.86
+1.4%
$2.32
+168.7%
N/A$108.82M$300.80MN/A1,030
GUTS
Fractyl Health
3.7011 of 5 stars
$0.70
+9.7%
$5.40
+672.2%
N/A$101.14M$90KN/A102
LAKE
Lakeland Industries
3.0033 of 5 stars
$9.50
-6.6%
$15.20
+60.0%
N/A$100.04M$192.65MN/A2,600

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners